Could melatonin help kids with PTSD sleep better?

NCT ID NCT07418554

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether a slow-release form of melatonin can improve sleep in 120 children and adolescents (ages 2-17.5) with PTSD who have significant sleep disturbances. Participants will receive either melatonin or a placebo for 13 weeks. The study aims to see if melatonin increases total sleep time and reduces PTSD symptoms, daytime problems, and caregiver stress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
prolonged-release melatonin
What this could lead to
If it works, this could provide a safe, effective treatment for sleep problems in children with PTSD, improving their daytime functioning and mental health.
What could go wrong
This is an early-stage trial with only 120 participants. Melatonin may not work for PTSD-related sleep issues, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CURRENT SIGNIFICANT SLEEP DISTURBANCES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpitaux Universitaires de Strasbourg

    Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.